What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Disease
Michael Berk mostly deals with Psychiatry, Bipolar disorder, Internal medicine, Depression and Schizophrenia.
His studies in Psychiatry integrate themes in fields like Randomized controlled trial and MEDLINE.
His work deals with themes such as Intervention, Mood disorders and Clinical psychology, Mood, which intersect with Bipolar disorder.
His research integrates issues of Endocrinology, Psychosis and Placebo-controlled study in his study of Internal medicine.
His Depression research is multidisciplinary, relying on both Odds ratio, Mental health, Prospective cohort study, Risk factor and C-reactive protein.
His study looks at the relationship between Schizophrenia and topics such as Pharmacology, which overlap with Adjunctive treatment.
His most cited work include:
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. (988 citations)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. (988 citations)
- Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors (807 citations)
What are the main themes of his work throughout his whole career to date?
Michael Berk mainly focuses on Psychiatry, Bipolar disorder, Internal medicine, Depression and Clinical psychology.
His work on Psychiatry deals in particular with Mood, Schizophrenia, Major depressive disorder, First episode and Mental health.
In his study, Clinical trial is strongly linked to Randomized controlled trial, which falls under the umbrella field of Bipolar disorder.
His biological study spans a wide range of topics, including Placebo, Endocrinology and Placebo-controlled study.
His Depression research includes elements of Comorbidity, MEDLINE and Anxiety.
As part of his studies on Clinical psychology, Michael Berk often connects relevant subjects like Cognition.
He most often published in these fields:
- Psychiatry (60.27%)
- Bipolar disorder (46.30%)
- Internal medicine (37.51%)
What were the highlights of his more recent work (between 2018-2021)?
- Bipolar disorder (46.30%)
- Depression (28.94%)
- Internal medicine (37.51%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Bipolar disorder, Depression, Internal medicine, Psychiatry and Randomized controlled trial.
He specializes in Bipolar disorder, namely Mania.
Michael Berk has researched Depression in several fields, including Mental health, Epidemiology, Disease and Anxiety.
His Internal medicine research incorporates elements of Placebo-controlled study, Placebo, Oncology and MEDLINE.
Michael Berk conducts interdisciplinary study in the fields of Psychiatry and Clinical neurology through his research.
His Randomized controlled trial research incorporates elements of Meta-analysis, Clinical trial and Adjunctive treatment.
Between 2018 and 2021, his most popular works were:
- The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials (62 citations)
- A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo (36 citations)
- Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes. (34 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Depression, Bipolar disorder, Internal medicine, Major depressive disorder and Mental health are his primary areas of study.
His work carried out in the field of Depression brings together such families of science as Epidemiology, Disease, Bioinformatics and MEDLINE.
Psychiatry covers Michael Berk research in Bipolar disorder.
The Major depressive disorder study combines topics in areas such as Guideline, Adverse effect, Dementia and Clinical psychology.
Michael Berk works mostly in the field of Mental health, limiting it down to topics relating to Public health and, in certain cases, Reciprocity, Social environment, Gerontology and Urbanization.
His Schizophrenia research integrates issues from Adjunctive treatment, Psychosis, Cognition, Neuroprotection and Autism spectrum disorder.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
